U.S. Stem Cell, Inc. (USRM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 16, 2026
U.S. Stem Cell Market Cap
U.S. Stem Cell has a market cap or net worth of $66.15 thousand as of March 26, 2026. Its market cap has decreased by -97.21% in one year.
Market Cap
66.15K
Enterprise Value
n/a
Revenue
82.05K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 19, 2008, U.S. Stem Cell's market cap has decreased from 66.74M to 66.15K, a decrease of -99.90%. That is a compound annual growth rate of -31.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 66.15K | 9,892.60% |
| Dec 31, 2025 | 662.00 | -99.00% |
| Dec 31, 2024 | 66.15K | 9,892.60% |
| Dec 26, 2023 | 662.00 | -99.98% |
| Dec 30, 2022 | 3.05M | 0.79% |
| Dec 31, 2021 | 3.02M | -43.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GB Sciences | 153.72K |
| Immunotech Laboratories | 114.99K |
| CNBX Pharmaceuticals | 112.58K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |
| Affymax | 74.49K |
| Nascent Biotech | 69.14K |
| Vincerx Pharma | 66.48K |